{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T02:19:24Z","timestamp":1794622764495,"version":"4.9.1"},"reference-count":77,"publisher":"American Society of Hematology","issue":"10","license":[{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5,28]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Neutrophil NETosis is a unique form of cell death, characterized by the release of decondensed chromatin and antimicrobial contents to the extracellular space, which is involved in inflammation and thrombosis. However, the role of NETosis in the pathogenesis of immune-mediated thrombotic thrombocytopenic purpura (iTTP) and how a targeted therapy affects the accumulation of neutrophil extracellular traps (NETs) under flow remain unknown. Flow cytometry demonstrated that the percentage of neutrophils undergoing NETosis in whole blood from patients with iTTP on admission was significantly increased, with a concurrent decrease in the capacity of inducible NETosis by shigatoxin. After therapy, the percentage of H3Cit+MPO+ neutrophils was significantly reduced, with an improvement in inducible NETosis in these patients. Additionally, little to no NET and thrombus formation was detected underflow in the whole blood from patients with iTTP when platelet counts were very low, but the NET and thrombus formation was dramatically increased following therapy when platelet counts rose to \u226550\u00a0\u00d7 109\/L or were restored to normal with donor platelets. Similarly, there was no thrombus or NET accumulation under flow in the whole blood from vwf-\/- mice, but NET accumulation was significantly higher in Adamts13-\/- mice than in wild-type mice. Finally, recombinant ADAMTS13 or caplacizumab (or anfibatide) prevented NET and thrombus formation under flow in whole blood from patients with iTTP or from Adamts13-\/- mice. These results indicate that neutrophil NETosis and NET formation depend on platelets and von Willebrand factor (VWF) in iTTP, and a targeted therapy such as recombinant ADAMTS13 or caplacizumab may prevent NET and thrombus formation under flow in iTTP.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2023011617","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T18:48:14Z","timestamp":1711046894000},"page":"2536-2551","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":22,"title":["Targeting neutrophil extracellular trap accumulation under flow in patients with immune-mediated thrombotic thrombocytopenic purpura"],"prefix":"10.1182","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8434-7399","authenticated-orcid":false,"given":"Noritaka","family":"Yada","sequence":"first","affiliation":[{"name":"1Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5916-9239","authenticated-orcid":false,"given":"Quan","family":"Zhang","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Bignotti","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah H.","family":"Gralnek","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Sosnovske","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keenan","family":"Hogan","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2378-3813","authenticated-orcid":false,"given":"Zhan","family":"Ye","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zheng","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS"},{"name":"2Institute of Reproductive Medicine and Developmental Sciences, The University of Kansas Medical Center, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1680-5295","authenticated-orcid":false,"given":"X. Long","family":"Zheng","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS"},{"name":"2Institute of Reproductive Medicine and Developmental Sciences, The University of Kansas Medical Center, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,5,21]]},"reference":[{"issue":"8","key":"2024052418101079800_bib1","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1182\/blood.V91.8.2839.2839_2839_2846","article-title":"Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura","volume":"91","author":"Furlan","year":"1998","journal-title":"Blood"},{"issue":"22","key":"2024052418101079800_bib2","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N\u00a0Eng J Med"},{"issue":"9","key":"2024052418101079800_bib3","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2009.019299","article-title":"Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura","volume":"95","author":"Zheng","year":"2010","journal-title":"Haematologica"},{"issue":"6","key":"2024052418101079800_bib4","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.jtha.2023.02.011","article-title":"Autoantibodies enhance ADAMTS-13 clearance in patients with immune thrombotic thrombocytopenic purpura","volume":"21","author":"Underwood","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"issue":"3","key":"2024052418101079800_bib5","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1182\/blood-2005-01-0152","article-title":"Localization of ADAMTS13 to the stellate cells of human liver","volume":"106","author":"Uemura","year":"2005","journal-title":"Blood"},{"issue":"6","key":"2024052418101079800_bib6","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/labinvest.3700275","article-title":"ADAMTS13 is expressed in hepatic stellate cells","volume":"85","author":"Zhou","year":"2005","journal-title":"Lab Invest"},{"issue":"7","key":"2024052418101079800_bib7","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1182\/blood-2006-02-002139","article-title":"Apical sorting of ADAMTS13 in vascular endothelial cells and Madin-Darby canine kidney cells depends on the CUB domains and their association with lipid rafts","volume":"108","author":"Shang","year":"2006","journal-title":"Blood"},{"issue":"5","key":"2024052418101079800_bib8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000252818","article-title":"Regulation of ADAMTS13 expression in proliferating human umbilical vein endothelial cells","volume":"36","author":"Kling","year":"2008","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"12","key":"2024052418101079800_bib9","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1182\/blood-2002-05-1401","article-title":"ADAMTS-13 rapidly cleaves newly secreted ultra large von Willebrand factor multimers on the endothelial surface under flowing conditions","volume":"100","author":"Dong","year":"2002","journal-title":"Blood"},{"issue":"18","key":"2024052418101079800_bib10","doi-asserted-by":"crossref","first-page":"11552","DOI":"10.1073\/pnas.192448999","article-title":"A\u00a0new name in thrombosis, ADAMTS13","volume":"99","author":"Sadler","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024052418101079800_bib11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev-med-061813-013241","article-title":"ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura","volume":"66","author":"Zheng","year":"2015","journal-title":"Annu Rev Med"},{"issue":"6","key":"2024052418101079800_bib12","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1056\/NEJM199108083250605","article-title":"Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients","volume":"325","author":"Bell","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"2024052418101079800_bib13","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0950-3536(98)80064-4","article-title":"Deficiency of von Willebrand factor-cleaving protease in familial and acquired thrombotic thrombocytopenic purpura","volume":"11","author":"Furlan","year":"1998","journal-title":"Baillieres Clin Haematol"},{"issue":"11","key":"2024052418101079800_bib14","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1182\/blood-2003-11-4035","article-title":"Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura","volume":"103","author":"Zheng","year":"2004","journal-title":"Blood"},{"issue":"10","key":"2024052418101079800_bib15","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/jth.15010","article-title":"ISTH guidelines for treatment of thrombotic thrombocytopenic purpura","volume":"18","author":"Zheng","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"8","key":"2024052418101079800_bib16","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1111\/jth.15406","article-title":"The standard of care for immune thrombotic thrombocytopenic purpura today","volume":"19","author":"Zheng","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"2024052418101079800_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF02981975","article-title":"Von Willebrand factor-cleaving protease and Upshaw Schulman syndrome","volume":"75","author":"Fujimura","year":"2002","journal-title":"Int J Hematol"},{"issue":"1","key":"2024052418101079800_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2169\/internalmedicine.49.2706","article-title":"Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998-2008","volume":"49","author":"Fujimura","year":"2010","journal-title":"Intern Med"},{"issue":"19","key":"2024052418101079800_bib19","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood-2017-06-788026","article-title":"Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura","volume":"130","author":"Scully","year":"2017","journal-title":"Blood"},{"issue":"Suppl 1","key":"2024052418101079800_bib20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1538-7836.2011.04341.x","article-title":"Natural history of Upshaw-Schulman syndrome based on ADAMTS13 gene analysis in Japan","volume":"9","author":"Fujimura","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"issue":"10","key":"2024052418101079800_bib21","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1172\/JCI26007","article-title":"Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice","volume":"115","author":"Motto","year":"2005","journal-title":"J\u00a0Clin Invest"},{"issue":"18","key":"2024052418101079800_bib22","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood-2010-02-271957","article-title":"Shiga toxin B subunits induce VWF secretion by human endothelial cells and thrombotic microangiopathy in ADAMTS13-deficient mice","volume":"116","author":"Huang","year":"2010","journal-title":"Blood"},{"issue":"19","key":"2024052418101079800_bib23","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1182\/blood-2013-02-486779","article-title":"AAV-mediated expression of an ADAMTS13 variant prevents shigatoxin-induced thrombotic thrombocytopenic purpura","volume":"121","author":"Jin","year":"2013","journal-title":"Blood"},{"issue":"13","key":"2024052418101079800_bib24","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1182\/blood-2005-05-2111","article-title":"Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers","volume":"106","author":"Nolasco","year":"2005","journal-title":"Blood"},{"issue":"12","key":"2024052418101079800_bib25","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.3390\/biomedicines9121807","article-title":"Shiga toxin 2a induces NETosis via NOX-dependent pathway","volume":"9","author":"Feitz","year":"2021","journal-title":"Biomedicines"},{"issue":"13","key":"2024052418101079800_bib26","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1182\/blood.2019001040","article-title":"Synergistic effects of ADAMTS13 deficiency and complement activation in pathogenesis of thrombotic microangiopathy","volume":"134","author":"Zheng","year":"2019","journal-title":"Blood"},{"issue":"4","key":"2024052418101079800_bib27","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00281-013-0384-6","article-title":"Molecular mechanisms regulating NETosis in infection and disease","volume":"35","author":"Branzk","year":"2013","journal-title":"Semin Immunopathol"},{"issue":"3","key":"2024052418101079800_bib28","doi-asserted-by":"crossref","first-page":"158","DOI":"10.5152\/tpd.2016.4936","article-title":"Netosis: alternative defense method used by neutrophils to fight pathogen","volume":"40","author":"Yildiz","year":"2016","journal-title":"Turkiye Parazitol Derg"},{"issue":"12","key":"2024052418101079800_bib29","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/ajh.24185","article-title":"Flow cytometric assay for direct quantification of neutrophil extracellular traps in blood samples","volume":"90","author":"Gavillet","year":"2015","journal-title":"Am J Hematol"},{"issue":"4","key":"2024052418101079800_bib30","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/ijlh.12800","article-title":"Quantification of NETs-associated markers by flow cytometry and serum assays in patients with thrombosis and sepsis","volume":"40","author":"Lee","year":"2018","journal-title":"Int J Lab Hematol"},{"issue":"3","key":"2024052418101079800_bib31","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/cyto.a.23672","article-title":"A\u00a0flow cytometry-based assay for high-throughput detection and quantification of neutrophil extracellular traps in mixed cell populations","volume":"95","author":"Zharkova","year":"2019","journal-title":"Cytometry A"},{"issue":"1","key":"2024052418101079800_bib32","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s41467-019-09160-7","article-title":"Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia","volume":"10","author":"Perdomo","year":"2019","journal-title":"Nat Commun"},{"issue":"2","key":"2024052418101079800_bib33","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/jth.15176","article-title":"Plasma levels of S100A8\/A9, histone\/DNA complexes, and cell-free DNA predict adverse outcomes of immune thrombotic thrombocytopenic purpura","volume":"19","author":"Sui","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"2024052418101079800_bib34","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1182\/blood-2012-02-412197","article-title":"Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies","volume":"120","author":"Fuchs","year":"2012","journal-title":"Blood"},{"issue":"1","key":"2024052418101079800_bib35","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3324\/haematol.2018.198275","article-title":"Clinical factors and biomarkers predict outcome in patients with immune-mediated thrombotic thrombocytopenic purpura","volume":"104","author":"Staley","year":"2019","journal-title":"Haematologica"},{"issue":"10","key":"2024052418101079800_bib36","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1111\/jth.15006","article-title":"ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura","volume":"18","author":"Zheng","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"11","key":"2024052418101079800_bib37","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1161\/ATVBAHA.118.311407","article-title":"Transfusion of platelets loaded with recombinant ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats-13) is efficacious for inhibiting arterial thrombosis associated with thrombotic thrombocytopenic purpura","volume":"38","author":"Abdelgawwad","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"33","key":"2024052418101079800_bib38","doi-asserted-by":"crossref","first-page":"29428","DOI":"10.1074\/jbc.M505513200","article-title":"The proximal carboxyl-terminal domains of ADAMTS13 determine substrate specificity and are all required for cleavage of von Willebrand factor","volume":"280","author":"Ai","year":"2005","journal-title":"J\u00a0Biol Chem"},{"issue":"6","key":"2024052418101079800_bib39","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1182\/blood-2007-04-083329","article-title":"The cooperative activity between the carboxyl-terminal TSP1 repeats and the CUB domains of ADAMTS13 is crucial for recognition of von Willebrand factor under flow","volume":"110","author":"Zhang","year":"2007","journal-title":"Blood"},{"issue":"11","key":"2024052418101079800_bib40","first-page":"1182","article-title":"Integrated genomic analysis identifies ANKRD36 gene as a novel and common biomarker of disease progression in chronic myeloid leukemia","volume":"10","author":"Iqbal","year":"2021","journal-title":"Biology (Basel)"},{"issue":"5","key":"2024052418101079800_bib41","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1189\/jlb.3TA0315-082R","article-title":"Platelet-neutrophil complex formation-a detailed in\u00a0vitro analysis of murine and human blood samples","volume":"99","author":"Mauler","year":"2016","journal-title":"J\u00a0Leukoc Biol"},{"issue":"24","key":"2024052418101079800_bib42","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1182\/bloodadvances.2019000939","article-title":"Longitudinal assessments of plasma ADAMTS13 biomarkers predict recurrence of immune thrombotic thrombocytopenic purpura","volume":"3","author":"Sui","year":"2019","journal-title":"Blood Adv"},{"issue":"21","key":"2024052418101079800_bib43","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1073\/pnas.0801735105","article-title":"Factor VIII accelerates proteolytic cleavage of von Willebrand factor by ADAMTS13","volume":"105","author":"Cao","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"112","key":"2024052418101079800_bib44","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1038\/ki.2008.615","article-title":"Shiga toxin-associated hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: distinct mechanisms of pathogenesis","volume":"75","author":"Tarr","year":"2009","journal-title":"Kidney Int"},{"issue":"21","key":"2024052418101079800_bib45","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1182\/blood-2014-07-587139","article-title":"Platelet-delivered ADAMTS13 inhibits arterial thrombosis and prevents thrombotic thrombocytopenic purpura in murine models","volume":"125","author":"Pickens","year":"2015","journal-title":"Blood"},{"key":"2024052418101079800_bib46","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1182\/bloodadvances.2016000711","article-title":"Therapeutic efficacy of the platelet glycoprotein Ib antagonist anfibatide in murine models of thrombotic thrombocytopenic purpura","volume":"1","author":"Zheng","year":"2016","journal-title":"Blood Adv"},{"issue":"2","key":"2024052418101079800_bib47","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1053\/beha.2001.0142","article-title":"Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: the role of von Willebrand factor-cleaving protease","volume":"14","author":"Furlan","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"issue":"2","key":"2024052418101079800_bib48","first-page":"267","article-title":"Thrombotic thrombocytopenic purpura in early pregnancy","volume":"66","author":"Ambrose","year":"1985","journal-title":"Obstet Gynecol"},{"issue":"4","key":"2024052418101079800_bib49","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1423-0410.2004.00560.x","article-title":"Thrombotic thrombocytopenic purpura and pregnancy: a review of ten cases","volume":"87","author":"Castella","year":"2004","journal-title":"Vox Sang"},{"issue":"8","key":"2024052418101079800_bib50","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1055\/s-2007-994069","article-title":"Coagulation and fibrinolysis parameters in normal pregnancy and in gestational diabetes","volume":"15","author":"Bellart","year":"1998","journal-title":"Am J Perinatol"},{"issue":"6","key":"2024052418101079800_bib51","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1055\/s-0037-1615035","article-title":"Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy","volume":"79","author":"Clark","year":"1998","journal-title":"Thromb Haemost"},{"issue":"2","key":"2024052418101079800_bib52","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0015-0282(16)54483-5","article-title":"Cytokine involvement in oocytes and early embryos","volume":"56","author":"Zolti","year":"1991","journal-title":"Fertil Steril"},{"issue":"4","key":"2024052418101079800_bib53","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00404-003-0547-0","article-title":"Serum TNF-alpha, IL-6, lupus anticoagulant and anticardiolipin antibody in women with and without a past history of recurrent miscarriage","volume":"270","author":"Arslan","year":"2004","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"2024052418101079800_bib54","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1177\/1933719112459237","article-title":"Tumor necrosis factor-alpha gene polymorphisms in Korean patients with recurrent spontaneous abortion","volume":"20","author":"Lee","year":"2013","journal-title":"Reprod Sci"},{"issue":"5663","key":"2024052418101079800_bib55","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"issue":"1","key":"2024052418101079800_bib56","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"36","key":"2024052418101079800_bib57","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"Fuchs","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2024052418101079800_bib58","first-page":"67","article-title":"PAMPs and DAMPs as triggers for DIC","volume":"2","author":"Ito","year":"2014","journal-title":"J\u00a0Intensive Care"},{"issue":"9","key":"2024052418101079800_bib59","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1161\/ATVBAHA.117.309817","article-title":"Targeting von Willebrand factor-mediated inflammation","volume":"37","author":"Drakeford","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"16","key":"2024052418101079800_bib60","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1182\/blood-2013-07-516484","article-title":"Synchronized integrin engagement and chemokine activation is crucial in neutrophil extracellular trap-mediated sterile inflammation","volume":"123","author":"Rossaint","year":"2014","journal-title":"Blood"},{"issue":"16","key":"2024052418101079800_bib61","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1182\/blood.2020008345","article-title":"Impaired adhesion of neutrophils expressing Slc44a2\/HNA-3b to VWF protects against NETosis under venous shear rates","volume":"137","author":"Zirka","year":"2021","journal-title":"Blood"},{"issue":"5","key":"2024052418101079800_bib62","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/jth.12796","article-title":"Impaired DNase1-mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies","volume":"13","author":"Jimenez-Alcazar","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"2024052418101079800_bib63","first-page":"461","article-title":"Impaired degradation of neutrophil extracellular traps: a possible severity factor of elderly male COVID-19 patients","volume":"14","author":"de Buhr","year":"2022","journal-title":"J\u00a0Innate Immun"},{"key":"2024052418101079800_bib64","doi-asserted-by":"crossref","first-page":"120389","DOI":"10.1016\/j.biomaterials.2020.120389","article-title":"Long-acting nanoparticulate DNase-1 for effective suppression of SARS-CoV-2-mediated neutrophil activities and cytokine storm","volume":"267","author":"Lee","year":"2021","journal-title":"Biomaterials"},{"issue":"4","key":"2024052418101079800_bib65","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1186\/ar4264","article-title":"Degradation of neutrophil extracellular traps co-varies with disease activity in patients with systemic lupus erythematosus","volume":"15","author":"Leffler","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"2024052418101079800_bib66","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.4049\/jimmunol.1102404","article-title":"Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease","volume":"188","author":"Leffler","year":"2012","journal-title":"J\u00a0Immunol"},{"issue":"10","key":"2024052418101079800_bib67","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1182\/blood.2019002329","article-title":"Fc-modified HIT-like monoclonal antibody as a novel treatment for sepsis","volume":"135","author":"Gollomp","year":"2020","journal-title":"Blood"},{"issue":"5","key":"2024052418101079800_bib68","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nm.3547","article-title":"Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines","volume":"20","author":"Schauer","year":"2014","journal-title":"Nat Med"},{"issue":"1","key":"2024052418101079800_bib69","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.1038\/s41467-022-32946-1","article-title":"NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia","volume":"13","author":"Leung","year":"2022","journal-title":"Nat Commun"},{"key":"2024052418101079800_bib70","first-page":"929743","article-title":"ETosis: a microbicidal mechanism beyond cell death","volume":"2012","author":"Guimaraes-Costa","year":"2012","journal-title":"J\u00a0Parasitol Res"},{"issue":"4","key":"2024052418101079800_bib71","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/cdd.2011.1","article-title":"Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality","volume":"18","author":"Remijsen","year":"2011","journal-title":"Cell Death Differ"},{"issue":"2","key":"2024052418101079800_bib72","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/cr.2010.150","article-title":"Neutrophil extracellular trap cell death requires both autophagy and superoxide generation","volume":"21","author":"Remijsen","year":"2011","journal-title":"Cell Res"},{"issue":"9","key":"2024052418101079800_bib73","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.jtha.2023.04.044","article-title":"Recombinant human DNase-I improves acute respiratory distress syndrome via neutrophil extracellular trap degradation","volume":"21","author":"Jarrahi","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"issue":"3","key":"2024052418101079800_bib74","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1538-7836.2007.02865.x","article-title":"Platelets, neutrophils, and neutrophil extracellular traps (NETs) in sepsis","volume":"6","author":"Ma","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"2024052418101079800_bib75","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1505533","article-title":"Caplacizumab for acquired thrombotic thrombocytopenic purpura","volume":"374","author":"Peyvandi","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"2024052418101079800_bib76","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa1806311","article-title":"Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura","volume":"380","author":"Scully","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"2024052418101079800_bib77","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1160\/TH13-06-0490","article-title":"Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in\u00a0vitro and in\u00a0vivo in murine models of thrombosis","volume":"111","author":"Lei","year":"2014","journal-title":"Thromb Haemost"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/10\/2536\/2226555\/blooda_adv-2023-011617-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/10\/2536\/2226555\/blooda_adv-2023-011617-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T18:10:47Z","timestamp":1716574247000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/10\/2536\/515379\/Targeting-neutrophil-extracellular-trap"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,21]]},"references-count":77,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,5,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023011617","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,21]]}}}